232 related articles for article (PubMed ID: 34074270)
1. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease.
Alqahtani SA; Broering DC; Alghamdi SA; Bzeizi KI; Alhusseini N; Alabbad SI; Albenmousa A; Alfaris N; Abaalkhail F; Al-Hamoudi WK
BMC Gastroenterol; 2021 Jun; 21(1):245. PubMed ID: 34074270
[TBL] [Abstract][Full Text] [Related]
2. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
4. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
Belli LS; Perricone G; Adam R; Cortesi PA; Strazzabosco M; Facchetti R; Karam V; Salizzoni M; Andujar RL; Fondevila C; De Simone P; Morelli C; Fabregat-Prous J; Samuel D; Agarwaal K; Moreno Gonzales E; Charco R; Zieniewicz K; De Carlis L; Duvoux C;
J Hepatol; 2018 Oct; 69(4):810-817. PubMed ID: 29940268
[TBL] [Abstract][Full Text] [Related]
5. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
Shirazi F; Wang J; Wong RJ
J Clin Exp Hepatol; 2020; 10(1):30-36. PubMed ID: 32025164
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma.
Singal AK; Satapathy SK; Reau N; Wong R; Kuo YF
Dig Liver Dis; 2020 Jan; 52(1):98-101. PubMed ID: 31582326
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Holzner ML; Florman S; Schwartz ME; Tabrizian P
HPB (Oxford); 2022 Apr; 24(4):470-477. PubMed ID: 34544629
[TBL] [Abstract][Full Text] [Related]
9. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
[TBL] [Abstract][Full Text] [Related]
12. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
13. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agents.
Dirchwolf M; Marciano S; Giunta DH; Posadas-Martínez ML; Biggins SW; Ruf AE
Clin Transplant; 2018 Apr; 32(4):e13230. PubMed ID: 29485711
[TBL] [Abstract][Full Text] [Related]
14. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
15. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
Flemming JA; Kim WR; Brosgart CL; Terrault NA
Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
18. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey.
Serin A; Sahin T; Arikan BT; Emek E; Bozkurt B; Tokat Y
Transplant Proc; 2019 Sep; 51(7):2416-2419. PubMed ID: 31402253
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India.
Jothimani D; Danielraj S; Narasimhan G; Kaliamoorthy I; Rajakumar A; Palaniappan K; Palanichamy S; Rammohan A; Ramachandran H; Rajalingam R; Rela M
J Clin Exp Hepatol; 2022; 12(3):908-916. PubMed ID: 35677507
[TBL] [Abstract][Full Text] [Related]
20. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
